Gene · 2775
Papers1,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Introducing ICAM1 as a possible drug target in treatment of eosinophilic esophagitis. | Gastroenterol Hepatol Bed Bench | 2025 | 42137123 | PubTator, text mining | PubMed |
| Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insights. | Mol Autism | 2025 | 41387899 | PubTator, text mining | PubMed |
| The GNAO1-B Splice Variant Is the Predominant Isoform in Human Astrocytes and Localizes to Retraction Fibers and Migrasomes. | Cells | 2025 | 41294808 | PubTator, text mining | PubMed |
| Beyond the Genotype: A Multi-Omic Analysis of APOEe4's Role in Alzheimer's Disease. | bioRxiv | 2025 | 41279801 | PubTator, text mining | PubMed |
| Episodic Choreo-Dystonic Storm in an Infantile-Onset Movement Disorder: Think of G Protein Subunit Alpha O1 Gene Defect! | Ann Indian Acad Neurol | 2025 | 41190407 | PubTator, text mining | PubMed |
| Severe upper airway dysfunction in GNAO1-related disorders. | Ital J Pediatr | 2025 | 41153036 | PubTator, text mining | PubMed |
| Loss of the conserved switch III region in a G protein leads to severe pediatric encephalopathy. | Sci Signal | 2025 | 41150825 | PubTator, text mining | PubMed |
| [Neurodevelopmental and Movement Disorder Due to a Mutation in the GNAO1 Gene: A Case Report]. | Rev Neurol | 2025 | 41074486 | PubTator, text mining | PubMed |
| Irregular vomeronasal system of hedgehogs is intermediate between segregated and uniform: how was type-2 receptor (V2R)-pathway in Laurasiatheria lost during evolution? | Chem Senses | 2025 | 40974013 | PubTator, text mining | PubMed |
| Dysregulation of G protein subunits in autism: decreased GNAO1 and elevated GNAI1 levels in ASD. | Front Psychiatry | 2025 | 40873676 | PubTator, text mining | PubMed |
| Effectiveness of Pallidal Stimulation for Dystonic Storm and Subsequent Ssevere Posterior Reversible Encephalopathy Syndrome in a Patient with GNAO1 Variant. | Acta Med Okayama | 2025 | 40859447 | PubTator, text mining | PubMed |
| KYNU is a potential metabolic-related biomarker for nasopharyngeal carcinoma by Raman spectroscopy, metabolomics, and transcriptomics analysis. | Discov Oncol | 2025 | 40844682 | PubTator, text mining | PubMed |
| Identification of three novel GNAO1 variants in a Chinese cohort with GNAO1 encephalopathy: expanding the clinical and genetic spectrum. | Orphanet J Rare Dis | 2025 | 40826482 | PubTator, text mining | PubMed |
| Signalling pathways and cellular functions of KDEL receptors: implications in cancer biology. | Cell Mol Life Sci | 2025 | 40767982 | PubTator, text mining | PubMed |
| Dominant Gα mutations in human disease: unifying mechanisms and treatment strategies. | EMBO Mol Med | 2025 | 40745211 | PubTator, text mining | PubMed |
| Neuronal oscillatory imbalances in GNAO1-related disorders associated with disease severity. | Epilepsia | 2025 | 40576155 | PubTator, text mining | PubMed |
| Clinical-molecular profiling of atypical GNAO1 patients: Novel pathogenic variants, unusual manifestations, and severe molecular dysfunction. | Genes Dis | 2025 | 40452885 | PubTator, text mining | PubMed |
| GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization. | Nat Commun | 2025 | 40374633 | PubTator, text mining | PubMed |
| Intracellular GPCR modulators enable precision pharmacology. | NPJ Drug Discov | 2025 | 40371403 | PubTator, text mining | PubMed |
| Novel Mutation at Cys225 in GNAO1-Associated Developmental and Epileptic Encephalopathies: Clinical, Molecular, and Pharmacological Profiling of Case Studies. | MedComm (2020) | 2025 | 40337144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2775/papers?page=3